Dry Eye Syndromes
📧 Sign up to get email alerts when something new happens for Dry Eye Syndromes.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2021-02-16Clinical Trial Update: Effect of Lifitegrast 5% on Tear Film Markers [Phase 4]
Phase 4 trial investigating Lifitegrast 5% effects on tear film markers has been withdrawn.
-
EMA withdrawal · 2018-08-06EMA Application withdrawn: Restaysis (ciclosporin) — Allergan Pharmaceuticals International Limited
The EMA withdrew the application for Restaysis (ciclosporin) by Allergan for dry eye syndromes.